Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2005 Jun;20(3):489-94.
doi: 10.3346/jkms.2005.20.3.489.

Clinical significance of Ki-67 labeling index in pituitary macroadenoma

Affiliations
Comparative Study

Clinical significance of Ki-67 labeling index in pituitary macroadenoma

Kyung-Il Paek et al. J Korean Med Sci. 2005 Jun.

Abstract

The aim of our study was to investigate the correlation of the proliferative activity of pituitary neoplasms with clinical characteristics and recurrences. Tumor specimens were obtained from 44 consecutive patients with pituitary macroadenomas who underwent surgery between July 1998 and August 2003. Specimens were immediately fixed in 10% buffered formalin and then embedded in paraffin. The Ki-67 antigen was assessed by immumohistochemical analysis using the monoclonal antibody. We investigated the correlation of the Ki-67 labeling index with the following clinical and radiological characteristics: sex, age, presence or absence visual field defect, tumor classification, maximal tumor diameter, Hardy's classification, type of tumor, invasiveness, and recurrence. Our study suggests that the clinical characteristics such as visual field defect and recurrence are correlated with the high Ki-67 labeling index. No statistical differences were observed in the Ki-67 labeling index in relation to the following characteristics: sex, age, tumor classification, maximal tumor diameter, Hardy's classification, type of tumor, and invasiveness into the sphenoid sinus or cavernous sinus.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Coronal T1-weighted magnetic resonance (MR) images for radiological invasion of pituitary macroadenoma. Gadolinum-enhanced coronal image (A) shows a homogeneously enhanced intrasellar mass with invasion into the cavernous sinus. Gadolinum-enhanced coronal image (B) shows a homogeneously enhanced intrasellar mass without invasion. In adenomas with invasion, the Ki-67 labeling index was higher than those without invasion.
Fig. 2
Fig. 2
Immunostaining for Ki-67 in pituitary macroadenoma. Only the dark brown stained nuclei were considered as immunopositive. (A) The Ki-67 labeling index in recurrent pituitary macroadenoma (3.5%) (original magnification, ×400). (B) The Ki-67 labeling index in non-recurrent pituitary macroadenoma (1%) (original magnification, ×400). The Ki-67 labeling index was higher in recurrent cases than in those without recurrence.

Similar articles

Cited by

References

    1. Pizaro CB, Oliveira MC, Coutinho LB, Ferreira NP. Measurement of Ki-67 antigen in 159 pituitary adenomas using the MIB-1 monoclonal antibody. Braz J Med Biol Res. 2004;37:235–243. - PubMed
    1. Losa M, Franzin A, Mangili F, Terreni MR, Barzaghi R, Veglia F, Mortini P, Giovanelli M. Proliferation index of non-functioning pituitary adenomas: correlations with clinical characteristics and long-term follow-up results. Neurosugery. 2000;47:1313–1319. - PubMed
    1. Sassolas G, Trouillas J, Treluyer C, Perrin G. Management of non-functioning pituitary adenomas. Acta Endocrinol (Copenh) 1993;129:21–26. - PubMed
    1. Petruson B, Jakobsson KE, Elfverson J, Bengtsson BA. Five-year follow-up of nonsecreting pituitary adenomas. Arch Otolaryngol Head Neck Surg. 1995;121:317–322. - PubMed
    1. Shone GR, Richards SH, Hourihan MD, Hall R, Thomas JP, Scanlon MF. Non-secretary adenomas of the pituitary treated by transethmoidal sellotomy. J R Soc Med. 1991;84:140–143. - PMC - PubMed

Publication types